[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Country Data (17 Countries), and Competitive Landscape – Analysis and Forecast, 2018-2029

February 2020 | 189 pages | ID: G6A896F94F35EN
BIS Research Inc.

US$ 4,500.00 US$ 5,000.00 -10 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.

Key Questions Answered in this Report:
  • What are the major market drivers, challenges, and opportunities in the global single cell sequencing market?
  • What are the underlying structures resulting in the emerging trends within the global single cell sequencing market?
  • How is each segment of the global single cell sequencing market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global single cell sequencing market? What are the major segments of these applications?
  • Who are the key manufacturers the global single cell sequencing market, and what are their contributions?
Global Single Cell Sequencing Market Forecast

The single cell sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029. The single cell sequencing market generated $1,234.0 million revenue in 2018, in terms of value. The global single cell sequencing market growth has been primarily attributed to the major drivers in this market such as increasing focus on non-invasive therapy by decreasing dependence on trial and error medicine, analysis of gene expression level and protein expression level simultaneously through single cell genomics, emergence of new sequencing techniques, and advancements in cell isolation techniques. However, there are significant challenges which are restraining the market growth. These challenges include the uncertain reimbursement and regulatory policies, high capital requirement, unavailability of bioinformatics solutions, and high cost of targeted therapeutic drugs and gene sequencing procedures.

Expert Quote

“Research programs such as Single Cell Analysis Project and Human Cell Atlas have been initiated to enhance this technology, consequentially increasing the awareness and adoption among patients and healthcare providers.”

Scope of the Market Intelligence on the Single Cell Sequencing Market

The single cell sequencing research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global single cell sequencing market.

Market Segmentation

The global single cell sequencing market segmentation (on the basis of product) is segmented into instrument and consumables.

The global single cell sequencing market segmentation (on the basis of workflow) is segmented into ingle cell isolation, single cell preparation, and single cell analysis.

The global single cell sequencing market segmentation (on the basis of end user) is segmented into academic & research laboratories, biotechnology & biopharmaceutical companies, and others end user segment.

The global single cell sequencing market segmentation (on the basis of application) is segmented into oncology, immunology, neurology, prenatal diagnosis (NIPT), microbiology, and others.

The global single cell sequencing market segmentation (on the basis of region) is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

Key Companies in the Single Cell Sequencing Market

The key manufacturers who have been contributing significantly to the global single cell sequencing market include 10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., Takara Bio, Inc., Perkin Elmer, and Inc. QIAGEN N.V., among others.
EXECUTIVE SUMMARY

1 RESEARCH SCOPE

1.1 Product Definition
1.2 Scope of the Study
1.3 Key Questions Answered in the Report

2 RESEARCH METHODOLOGY

2.1 Data Sources
  2.1.1 Primary Data Sources
  2.1.2 Secondary Data Sources
2.2 Market Estimation Model
  2.2.1 Factors Considered for Data Prediction and Modeling
  2.2.2 Assumptions and Limitations

3 MARKET DYNAMICS

3.1 Business Drivers
  3.1.1 Need for Non-Invasive Diagnosis
  3.1.2 Advancements in Single Cell Sequencing Techniques
  3.1.3 Increase in Adoption of Personalized Medicine
3.2 Business Challenges
  3.2.1 Lack of Tools for Computational Analysis
  3.2.2 High Capital Requirement
  3.2.3 Lack of Infrastructure and Expertise
3.3 Legal Requirements and Regulations
  3.3.1 Legal Requirements and Framework in the U.S.
  3.3.2 Legal Requirements and Regulations in Europe
  3.3.3 Legal Requirements and Framework in Asia-Pacific
    3.3.3.1 China
    3.3.3.2 Japan
3.4 Opportunity MAP (Markets – Applications – Products)
  3.4.1 Expansion into Emerging Markets
  3.4.2 Expansion into New Research Application
  3.4.3 Expansion of the Product Portfolio

4 GLOBAL SINGLE CELL SEQUENCING MARKET (BY WORKFLOW), 2018-2029

4.1 Single Cell Isolation
  4.1.1 Fluorescence-Activated Cell Sorting (FACS)
  4.1.2 Laser Capture Microdissection (LCM)
  4.1.3 Microfluidics
  4.1.4 Digital Dielectrophoretic Sorting (DEPArray)
  4.1.5 Other Technologies
4.2 Single Cell Amplification
  4.2.1 Multiple Displacement Amplification (MDA)
    4.2.1.1 Micro-Capillary Array Emulsion Multiple Displacement Amplification (MiCA-eMDA)
    4.2.1.2 Single Droplet Multiple Displacement Amplification (sd-MDA)
    4.2.1.3 Compartmented Droplet Multiple Displacement Amplification (Cd-MDA)
  4.2.2 Multiple Annealing and Looping-Bases Amplification (MALBAC)
  4.2.3 Polymerase Chain Reaction (ddPCR and DOP-PCR)
  4.2.4 Linear Amplification via Transposon Insertion (LIANTI)
  4.2.5 Other Technologies
4.3 Single Cell Sequencing
  4.3.1 Single Cell Transcriptome Sequencing (Sc-RNA Sequencing)
  4.3.2 Single Cell Whole Genome Sequencing (WGS)
  4.3.3 Single Cell Genome and Transcriptome Parallel Sequencing
  4.3.4 Single Cell Hi-C Sequencing
  4.3.5 Single Cell Reduced Representation Bisulfite Sequencing (scRRBS)
  4.3.6 Single Cell Whole-Genome Bisulfite Sequencing (WGBS)
4.4 Affiliated Technological Advancements
  4.4.1 Advancements in Imaging Techniques for Single Cell Sequencing
  4.4.2 Advancements in Single Cell Collection and Analysis System

5 GLOBAL SINGLE CELL SEQUENCING MARKET, BY PRODUCT, 2018-2029 ($MILLION)

5.1 Instruments
  5.1.1 Next-Generation Sequencing Systems
  5.1.2 Polymerase Chain Reaction
  5.1.3 Microarray Systems
  5.1.4 Flow Cytometer
  5.1.5 Others
5.2 Consumables
  5.2.1 Assay Kits
  5.2.2 Beads
  5.2.3 Microplates
  5.2.4 Other Consumables

6 GLOBAL SINGLE CELL SEQUENCING MARKET (BY APPLICATION), $MILLION, 2018-2029

6.1 Oncology
6.2 Immunology
6.3 Neurology
6.4 Microbiology
6.5 Pre-Natal Diagnosis (NIPT)
6.6 Others

7 GLOBAL SINGLE CELL SEQUENCING MARKET (BY END USER), $MILLION, 2018-2029

7.1 Single Cell Sequencing End User Types
  7.1.1 Research and Academic Laboratories
  7.1.2 Biopharmaceutical and Biotech Companies
  7.1.3 Others (Hospitals, Clinics, and Diagnostic Labs)
7.2 Single Cell Sequencing End User Preferences
  7.2.1 End User Preference and Satisfaction Level of Different Instruments (by Brand)
  7.2.2 End User Preference for Cell Types Used in Single Cell Sequencing
  7.2.3 End User Preferred Technology for Single Cell Isolation
  7.2.4 End User Perception for Challenges in Single Cell Sequencing

8 GLOBAL SINGLE CELL SEQUENCING MARKET: COMPETITIVE LANDSCAPE

8.1 Growth Rates and Market Shares of Key Players
8.2 Business Strategies
  8.2.1 Product Launches
  8.2.2 Expanding Presence through Partnerships, Joint Ventures, and Collaborations
8.3 Corporate Developments
  8.3.1 Mergers and Acquisitions
  8.3.2 Funding

9 GLOBAL SINGLE CELL SEQUENCING MARKET, BY REGION, 2018-2029 ($MILLION)

9.1 Overview
9.2 North America
  9.2.1 U.S.
  9.2.2 Canada
9.3 Europe
  9.3.1 Germany
  9.3.2 France
  9.3.3 U.K.
  9.3.4 Italy
  9.3.5 Spain
  9.3.6 Rest-of-Europe
9.4 Asia-Pacific
  9.4.1 China
  9.4.2 Japan
  9.4.3 Australia
  9.4.4 India
  9.4.5 South Korea
  9.4.6 Singapore
  9.4.7 Rest-of-APAC
9.5 Latin America
  9.5.1 Brazil
  9.5.2 Mexico
  9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World

10 COMPANY PROFILES

10.1 10x Genomics Inc.
  10.1.1 Company Overview
  10.1.2 Role of 10x Genomics Inc. in the Global Single Cell Sequencing Market
  10.1.3 SWOT Analysis
10.2 Becton, Dickinson and Company
  10.2.1 Company Overview
  10.2.2 Role of Becton, Dickinson and Company in the Global Single Cell Sequencing Market
  10.2.3 Key Insights About Financial Health of the Company
  10.2.4 SWOT Analysis
10.3 Bio-Rad Laboratories, Inc.
  10.3.1 Company Overview
  10.3.2 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell Sequencing Market
  10.3.3 Key Insights About Financial Health of the Company
  10.3.4 SWOT Analysis
10.4 BGI Genomics Co. Ltd.
  10.4.1 Company Overview
  10.4.2 Role of BGI in the Single-Cell Sequencing Market
  10.4.3 SWOT Analysis
10.5 Celsee Inc.
  10.5.1 Company Overview
  10.5.2 Role of Celsee Inc. in the Global Single Cell Sequencing Market
  10.5.3 SWOT Analysis
10.6 Fluidigm Corporation
  10.6.1 Company Overview
  10.6.2 Role of Fluidigm Corporation in the Global Single Cell Sequencing Market
  10.6.3 Key Insights About Financial Health of the Company
  10.6.4 SWOT ANALYSIS
10.7 Fluxion Biosciences
  10.7.1 Company Overview
  10.7.2 Role of Fluxion Biosciences in the Global Single Cell Sequencing Market
  10.7.3 SWOT Analysis
10.8 Illumina, Inc.
  10.8.1 Company Overview
  10.8.2 Role Illumina, Inc. in the Global Single Cell Sequencing Market
  10.8.3 Key Insights About Financial Health of the Company
  10.8.4 SWOT Analysis
10.9 Mission Bio
  10.9.1 Company Overview
  10.9.2 Role of Mission Bio in the Single Cell Sequencing Market
  10.9.3 SWOT Analysis
10.10 NanoString Technologies, Inc.
  10.10.1 Company Overview
  10.10.2 Role of NanoString Technologies, Inc. in the Global Single Cell Sequencing Market
  10.10.3 Key Insights About Financial Health of the Company
  10.10.4 SWOT Analysis
10.11 PerkinElmer, Inc.
  10.11.1 Company Overview
  10.11.2 Role of PerkinElmer, Inc. in the Global Single Cell Sequencing Market
  10.11.3 Key Insights About Financial Health of the Company
  10.11.4 SWOT Analysis
10.12 QIAGEN N.V.
  10.12.1 Company Overview
  10.12.2 Role of QIAGEN N.V. in the Global Single Cell Sequencing Market
  10.12.3 Key Insights About Financial Health of the Company
  10.12.4 SWOT Analysis
10.13 Takara Bio, Inc.
  10.13.1 Company Overview
  10.13.2 Role of Takara Bio, Inc. in the Global Single Cell Sequencing Market
  10.13.3 Key Insights About Financial Health of the Company
  10.13.4 SWOT Analysis
10.14 Thermo Fisher Scientific Inc.
  10.14.1 Company Overview
  10.14.2 Role of Thermo Fisher Scientific Inc. in the Global Single Cell Sequencing Market
  10.14.3 Financials
  10.14.4 Key Insights About Financial Health of the Company
  10.14.5 SWOT Analysis

LIST OF TABLES

Table 1: Impact Analysis
Table 2: Impact Analysis: Market Restraints
Table 3.1: Regulatory Bodies and Consortiums of Single Cell Sequencing Market
Table 3.2: Classification of Directive Groups IVDs
Table 4.1: Products for Fluorescence-Activated Cell Sorting
Table 4.2: Multiple Annealing and Looping-Based Amplification-Based Products for Single Cell Analysis
Table 4.3: PCR-Based Products for Single Cell Isolation
Table 4.4: Products Offered for Single Cell Transcriptome Sequencing
Table 4.5: Products Offered for Single Cell Whole Genome Sequencing
Table 8.1: Single Cell Sequencing Research Funding

LIST OF FIGURES

Figure 1: Market Dynamics of Global Single Cell Sequencing Market
Figure 2: Drivers of Next-Generation Sequencing Market
Figure 3: Restraints of Next-Generation Sequencing Market
Figure 4: Global Single Cell Sequencing Market Snapshot
Figure 5: Dominating Segments of the Global Single Cell Sequencing, 2018 and 2029
Figure 6: Global Single Cell Sequencing Market Share (by Product), 2018-2029
Figure 7: Global Single Cell Sequencing Market Share (by Workflow), 2018-2029
Figure 8: Global Single Cell Sequencing Market Share (by End User), 2018-2029
Figure 9: Global Single Cell Sequencing Market Share (by Application), 2018-2029
Figure 1.1: Global Single Cell Sequencing Market Segmentation
Figure 2.1: Global Single Cell Sequencing Market Research Methodology
Figure 2.2: Bottom-Up Approach (Segment-Wise Analysis)
Figure 2.3: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Single Cell Isolation Methods
Figure 4.2: Global Single Cell Isolation Market, 2018-2029
Figure 4.3: Global Single Cell Fluorescence-Activated Cell Sorting Market, 2018-2029
Figure 4.4: Global Single Cell Laser Capture Microdissection Market, 2018-2029
Figure 4.5: Global Single Cell Microfluidics Market, 2018-2029
Figure 4.6: Global Single Cell DEPArray Market, 2018-2029
Figure 4.7: Global Single Cell Other Single Cell Isolation Technologies Market, 2018-2029
Figure 4.8: Global Single Cell Sequencing Amplification Market, 2018-2029
Figure 4.9: Global Single Cell Sequencing Multiple Displacement Amplification Market, 2018-2029
Figure 4.10: Global Single Cell Micro-Capillary Array Emulsion Multiple Displacement Amplification Market, 2018-2029
Figure 4.11: Global Single Droplet Multiple Displacement Amplification Market, 2018-2029
Figure 4.12: Global Compartmented Droplet Multiple Displacement Amplification Market, 2018-2029
Figure 4.13: Global Single Cell MALBAC Market, 2018-2029
Figure 4.14: Global Single Cell Polymerase Chain Reaction (ddPCR and DOP-PCR) Market, 2018-2029
Figure 4.15: Global Single LIANTI Market, 2018-2029
Figure 4.16: Global Single Cell Other Amplification Technologies Market, 2018-2029
Figure 4.17: Global Single Cell Sequencing Market, 2018-2029
Figure 4.18: Global Single Cell Transcriptome Sequencing Market, 2018-2029
Figure 4.19: Global Single Cell Whole Genome Sequencing (WGS) Market, 2018-2029
Figure 4.20: Global Single Cell Genome and Transcriptome Parallel Sequencing Market, 2018-2029
Figure 4.21: Global Single Cell Hi-C Sequencing Market, 2018-2029
Figure 4.22: Global Single Cell Reduced Representation Bisulfide Sequencing Market, 2018-2029
Figure 4.23: Global Single Cell Whole Genome Bisulfite Sequencing Market, 2018-2029
Figure 4.24: Three Major Technological Developments in Single Cell Sequencing
Figure 4.25: Traditional and Modern Approaches for Single Cell Isolation
Figure 5.1: Global Single Cell Sequencing (by Product Type), 2018 and 2029
Figure 5.2: Global Single Cell Sequencing Instruments Market, 2018-2029
Figure 5.3: Global Single Cell Sequencing NGS System Market, 2018-2029
Figure 5.4: Global Single Cell Sequencing PCR Market, 2018-2029
Figure 5.5: Global Single Cell Sequencing Microarray Systems Market, 2018-2029
Figure 5.6: Global Single Cell Sequencing Flow Cytometer Market, 2018-2029
Figure 5.7: Global Single Cell Sequencing Other Instruments Market, 2018-2029
Figure 5.8: Global Single Cell Sequencing Consumables Market, 2018-2029
Figure 5.9: Global Single Cell Sequencing Assay Kits Market, 2018-2029
Figure 5.10: Global Single Cell Sequencing Beads Market, 2018-2029
Figure 5.11: Global Single Cell Sequencing Microplates Market, 2018-2029
Figure 5.12: Global Single Cell Sequencing Other Consumables Market, 2018-2029
Figure 6.1: Global Single Cell Sequencing Market for Oncology (2018-2029)
Figure 6.2: Global Single Cell Sequencing Market for Immunology (2018-2029)
Figure 6.3: Global Single Cell Sequencing Market for Neurology (2018-2029)
Figure 6.4: Global Single Cell Sequencing Market for Microbiology (2018-2029)
Figure 6.5: Global Single Cell Sequencing Pre-Natal Market (2018-2029)
Figure 6.6: Global Single Cell Sequencing Other Application Market (2018-2029)
Figure 7.1: Global Single Cell Sequencing Market (Research and Academia), 2018-2029
Figure 7.2: Global Single Cell Sequencing Market, (Biopharmaceutical and Biotech Companies), 2018-2029
Figure 7.3: Global Single Cell Sequencing Market (Others), 2018-2029
Figure 7.4: End User Preference of Instruments (by Major Brand) (N=35)
Figure 7.5: End User Satisfaction Level of Instruments (by Brand) (N=35) (1 being lowest and 5 being the highest)
Figure 7.6: Customer Preference for Cell Types Used in Single Cell Sequencing (N=35)
Figure 7.7: End User Preferred Technology for Single Cell Isolation (N=35)
Figure 7.8: End User Perception on Challenges in Single Cell Sequencing (N=35) (where 1= not limiting and 5= extremely limiting)
Figure 8.1: Growth Rate and Market Share Matrix for Global SCS Market, 2018
Figure 8.2: Market Shares of Key Players in Global Single Cell Sequencing Market, 2018
Figure 8.3: Product Launches Share (by Companies), January 2016–April 2019
Figure 8.4: Synergistic Activities Share (by Companies), January 2016 – April 2019
Figure 8.5: Number of Acquisitions (by Company), January 2016–April 2019
Figure 9.1: Global Single Cell Sequencing Market (by Region), 2018 and 2029
Figure 9.2: Global Single Cell Sequencing Market (by Region), 2018-2029
Figure 9.3: Global Single Cell Sequencing Market Share (by Region), 2018
Figure 9.4: Global Single cell Sequencing Market Share (by Region), 2029
Figure 9.5: North America Global Single Cell Sequencing Market, 2018-2029
Figure 9.6: North America: Market Dynamics
Figure 9.7: North America Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.8: U.S. Single Cell Sequencing Market, 2018-2029
Figure 9.9: Canada Single Cell Sequencing Market, 2018-2029
Figure 9.10: Europe Single Cell Sequencing Market, 2018-2029
Figure 9.11: Europe: Market Dynamics
Figure 9.12: Europe Global Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.13: Germany Single Cell Sequencing Market, 2018-2029
Figure 9.14: France Single Cell Sequencing Market, 2018-2029
Figure 9.15: U.K. Single Cell Sequencing Market, 2018-2029
Figure 9.16: Italy Single Cell Sequencing Market, 2018-2029
Figure 9 17: Spain Single Cell Sequencing Market, 2018-2029
Figure 9.18: Rest-of-Europe Single Cell Sequencing Market, 2018-2029
Figure 9.19: Asia-Pacific Single Cell Sequencing Market, 2018-2029
Figure 9.20: APAC: Market Dynamics
Figure 9.21: APAC Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.22: China Single Cell Sequencing Market, 2018-2029
Figure 9.23: Japan Single Cell Sequencing Market, 2018-2029
Figure 9.24: Australia Single Cell Sequencing Market, 2018-2029
Figure 9.25: India Single Cell Sequencing Market, 2018-2029
Figure 9.26: South Korea Single Cell Sequencing Market, 2018-2029
Figure 9.27: Singapore Single Cell Sequencing Market, 2018-2029
Figure 9.28: RoAPAC Single Cell Sequencing Market, 2018-2029
Figure 9.29: Latin America Single Cell Sequencing Market, 2018-2029
Figure 9.30: Latin America: Market Dynamics
Figure 9.31: Latin America Single Cell Sequencing Market (by Country), 2018-2029
Figure 9.32: Brazil Single Cell Sequencing Market, 2018-2029
Figure 9.33: Mexico Single Cell Sequencing Market, 2018-2029
Figure 9.34: Rest-of-Latin America Single Cell Sequencing Market, 2018-2029
Figure 9.35: RoW Single Cell Sequencing Market, 2018-2029
Figure 10.1: 10x Genomics Inc.: SWOT Analysis
Figure 10.2: Becton, Dickinson and Company: Overall Financials, 2016-2018
Figure 10.3: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2018
Figure 10.4: Becton, Dickinson and Company: Revenue (by Region), 2015-2018
Figure 10.5: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
Figure 10.6: Becton, Dickinson and Company: SWOT Analysis
Figure 10.7: Bio-Rad Laboratories, Inc.: Overall Financials, (2016-2018)
Figure 10.8: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.9: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
Figure 10.10: Bio-Rad Laboratories, Inc., R&D Expenditure, 2016-2018
Figure 10.11: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.12: BGI: SWOT Analysis
Figure 10.13: Celsee Inc.: SWOT Analysis
Figure 10.14: Fluidigm Corporation: Overall Financials, 2016-2018
Figure 10.15: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
Figure 10.16: Fluidigm Corporation: Revenue (by Region), 2016-2018
Figure 10.17: Fluidigm Corporation: R&D Expenditure, 2016-2018
Figure 10.18: Fluidigm Corporation: SWOT Analysis
Figure 10.19: Fluxion Biosciences: SWOT Analysis
Figure 10.20: Illumina Inc.: Overall Financials, (2016-2018)
Figure 10.21: Illumina, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.22: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 10.23: Illumina, Inc., R&D Expenditure, 2016-2018
Figure 10.24: Illumina, Inc. SWOT Analysis
Figure 10.25: Mission Bio: SWOT Analysis
Figure 10.26: NanoString Technologies, Inc.: Overall Financials, (2016-2018)
Figure 10.27: NanoString Technologies, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.28: NanoString Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 10.29: NanoString Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 10.30: NanoString Technologies, Inc.: R&D Expenditure (by Functional Area), 2016-2018
Figure 10.31: NanoString Technologies: SWOT Analysis
Figure 10.32: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 10.33: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.34: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 10.35: PerkinElmer, Inc., Inc.: R&D Expenditure, 2016-2018
Figure 10.36: PerkinElmer, Inc.: SWOT Analysis
Figure 10.37: QIAGEN N.V..: Overall Financials, (2015-2017)
Figure 10.38: QIAGEN N.V.: Revenue (by Business Segment), 2015-2017
Figure 10.39: QIAGEN N.V.: Revenue (by Region), 2015-2017
Figure 10.40: QIAGEN N.V.: R&D Expenditure, 2015-2017
Figure 10.41: QIAGEN N.V.: SWOT Analysis
Figure 10.42: Takara Bio Inc.: Overall Financials, (2016-2018)
Figure 10.43: Takara Bio, Inc.: Revenue (by Business Segment), 2016-2018
Figure 10.44: Takara Bio, Inc.: Revenue (by Region), 2017
Figure 10.45: Takara Bio, Inc., R&D Expenditure, 2015-2017
Figure 10.46: Takara Bio Inc.: SWOT Analysis
Figure 10.47: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 10.48: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 10.49: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 10.50: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 10.51: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 10.52: Thermo Fisher Scientific Inc.: SWOT Analysis


More Publications